Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival

Pseudomyxoma peritonei (PMP) is ideally treated by cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), leading to significant morbidity. Beyond the histologic grade, the prognosis lies in the completeness of cytoreduction (CC-score of 0/1 vs. 2/3) and the severe compl...

Full description

Bibliographic Details
Main Authors: Vahan Kepenekian, Amaniel Kefleyesus, David Keskin, Nazim Benzerdjeb, Isabelle Bonnefoy, Laurent Villeneuve, Omar Alhadeedi, Abeer Al-Otaibi, Alexandre Galan, Olivier Glehen, Julien Péron, Pascal Rousset
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/18/4434
_version_ 1797490300152709120
author Vahan Kepenekian
Amaniel Kefleyesus
David Keskin
Nazim Benzerdjeb
Isabelle Bonnefoy
Laurent Villeneuve
Omar Alhadeedi
Abeer Al-Otaibi
Alexandre Galan
Olivier Glehen
Julien Péron
Pascal Rousset
author_facet Vahan Kepenekian
Amaniel Kefleyesus
David Keskin
Nazim Benzerdjeb
Isabelle Bonnefoy
Laurent Villeneuve
Omar Alhadeedi
Abeer Al-Otaibi
Alexandre Galan
Olivier Glehen
Julien Péron
Pascal Rousset
author_sort Vahan Kepenekian
collection DOAJ
description Pseudomyxoma peritonei (PMP) is ideally treated by cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), leading to significant morbidity. Beyond the histologic grade, the prognosis lies in the completeness of cytoreduction (CC-score of 0/1 vs. 2/3) and the severe complication rate. The mucinous nature of the peritoneal implants sometimes induces liver and/or spleen scalloping on imaging. The predictive value of scalloping was assessed regarding resectability, grade, survival and severe morbidity. This monocentric, retrospective analysis compared CC-0/1 with CC-2/3 groups regarding liver and spleen scalloping parameters, assessed on pre-operative computed tomography (CT) scan, reviewed for the study. In addition, prognostic factors of severe complications and recurrence-free and overall survivals were explored in the CC-0/1 population. Overall, 129 patients were included (109 CC-0/1, 20 CC-2/3), with 58 (45%) exhibiting scalloping. All patients with splenic scalloping also had a liver one. Scalloping was more frequent (75% vs. 39%), with greater median maximal depth (21 vs. 11 mm) and higher PCI (32 vs. 14) in the CC-2/3 population, but was not predictive of either grade or survival. In CC-0/1 patients, survivals and postoperative complications were not affected by scalloping parameters. Scalloping appeared as a marker of advanced PMP, but was not predictive of grade, severe complications, or long-term outcomes.
first_indexed 2024-03-10T00:30:02Z
format Article
id doaj.art-dc67d900c6a14050a71ad62e2374821c
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T00:30:02Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-dc67d900c6a14050a71ad62e2374821c2023-11-23T15:27:13ZengMDPI AGCancers2072-66942022-09-011418443410.3390/cancers14184434Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and SurvivalVahan Kepenekian0Amaniel Kefleyesus1David Keskin2Nazim Benzerdjeb3Isabelle Bonnefoy4Laurent Villeneuve5Omar Alhadeedi6Abeer Al-Otaibi7Alexandre Galan8Olivier Glehen9Julien Péron10Pascal Rousset11Surgical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceSurgical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceDepartment of Radiology, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceCICLY-EA3738, Université Claude Bernard Lyon I (UCBL1), 69622 Lyon, FranceSurgical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceSurgical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceSurgical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceDepartment of Radiology, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceDepartment of Radiology, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceSurgical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceMedical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite, FranceCICLY-EA3738, Université Claude Bernard Lyon I (UCBL1), 69622 Lyon, FrancePseudomyxoma peritonei (PMP) is ideally treated by cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), leading to significant morbidity. Beyond the histologic grade, the prognosis lies in the completeness of cytoreduction (CC-score of 0/1 vs. 2/3) and the severe complication rate. The mucinous nature of the peritoneal implants sometimes induces liver and/or spleen scalloping on imaging. The predictive value of scalloping was assessed regarding resectability, grade, survival and severe morbidity. This monocentric, retrospective analysis compared CC-0/1 with CC-2/3 groups regarding liver and spleen scalloping parameters, assessed on pre-operative computed tomography (CT) scan, reviewed for the study. In addition, prognostic factors of severe complications and recurrence-free and overall survivals were explored in the CC-0/1 population. Overall, 129 patients were included (109 CC-0/1, 20 CC-2/3), with 58 (45%) exhibiting scalloping. All patients with splenic scalloping also had a liver one. Scalloping was more frequent (75% vs. 39%), with greater median maximal depth (21 vs. 11 mm) and higher PCI (32 vs. 14) in the CC-2/3 population, but was not predictive of either grade or survival. In CC-0/1 patients, survivals and postoperative complications were not affected by scalloping parameters. Scalloping appeared as a marker of advanced PMP, but was not predictive of grade, severe complications, or long-term outcomes.https://www.mdpi.com/2072-6694/14/18/4434pseudomyxoma peritonei (PMP)scallopingresectabilityprognostic factorrecurrence predictionsevere complications prediction
spellingShingle Vahan Kepenekian
Amaniel Kefleyesus
David Keskin
Nazim Benzerdjeb
Isabelle Bonnefoy
Laurent Villeneuve
Omar Alhadeedi
Abeer Al-Otaibi
Alexandre Galan
Olivier Glehen
Julien Péron
Pascal Rousset
Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival
Cancers
pseudomyxoma peritonei (PMP)
scalloping
resectability
prognostic factor
recurrence prediction
severe complications prediction
title Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival
title_full Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival
title_fullStr Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival
title_full_unstemmed Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival
title_short Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival
title_sort scalloping of the liver and spleen on preoperative ct scan of pseudomyxoma peritonei patients impact on prediction of resectability grade morbidity and survival
topic pseudomyxoma peritonei (PMP)
scalloping
resectability
prognostic factor
recurrence prediction
severe complications prediction
url https://www.mdpi.com/2072-6694/14/18/4434
work_keys_str_mv AT vahankepenekian scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT amanielkefleyesus scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT davidkeskin scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT nazimbenzerdjeb scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT isabellebonnefoy scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT laurentvilleneuve scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT omaralhadeedi scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT abeeralotaibi scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT alexandregalan scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT olivierglehen scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT julienperon scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival
AT pascalrousset scallopingoftheliverandspleenonpreoperativectscanofpseudomyxomaperitoneipatientsimpactonpredictionofresectabilitygrademorbidityandsurvival